Ken Fisher's position in Thermo Fisher Scientific is currently worth $1.41 Billion. That's 0.67% of their equity portfolio (45th largest holding). The first Thermo Fisher Scientific trade was made in Q4 2015. Since then Ken Fisher bought shares 23 more times and sold shares on ten occasions. The stake costed the investor $1.02 Billion, netting the investor a gain of 38% so far.
Applied Biosystems CytoScan Dx and Chromosome Analysis Suite (ChAS) Dx software provide complete solution to support cytogenetic testing Thermo Fisher Scient...
Finanz Nachrichten, 1 day agoNo summary available.
Seeking Alpha, 9 days agoBURLINGAME, CALIFORNIA, UNITED STATE, May 22, 2024 /EINPresswire.com/ -- The Recombinant Dna Technology Market is estimated for 2024 to 2031 for the foreca...
EIN News Lung Cancer, 10 days agoSymbotic, Intuitive Surgical, and Thermo Fisher Scientific are the 3 Best non-Nvidia (NASDAQ:NVDA) artificial intelligence (AI) stocks to buy in Ma…
TipRanks, 15 days ago